LENSAR Q2 Earnings Call Highlights

LENSAR NASDAQ: LNSR reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end of the first quarter.

MarketBeat • Aug 13, 2026

LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript

LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 13, 2026

LENSAR® Reports Second Quarter 2026 Results and Provides Business Update

10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026 Second Quarter Recurring Revenue was $13.7 million Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on key operational initiatives.

GlobeNewsWire • Aug 13, 2026

LENSAR Q1 Earnings Call Highlights

LENSAR NASDAQ: LNSR executives told investors on Thursday that the company is moving past a “transaction-related holding pattern” after the termination of its planned merger, and is now refocusing on rebuilding commercial momentum around its ALLY femtosecond laser cataract platform. Management said first-quarter results reflected that period of uncertainty, but highlighted continued growth in recurring revenue and rising procedure volumes.

MarketBeat • May 8, 2026

LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript

LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 8, 2026

LENSAR® Reports First Quarter 2026 Results and Provides Business Update

7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026

GlobeNewsWire • May 8, 2026

LENSAR® to Report First Quarter 2026 Results on May 8, 2026

ORLANDO, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company's first quarter 2026 financial results will be released before market open on Friday, May 8, 2026.

GlobeNewsWire • Apr 30, 2026

LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript

LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript

Seeking Alpha • Mar 31, 2026

LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

15 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, 2025

GlobeNewsWire • Mar 31, 2026

LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review

In March 2025, Alcon agreed to acquire the laser solutions company for $14.00 per share for an aggregate implied value of approximately $356 million.

Benzinga • Mar 17, 2026